Interestingly, Gomez-Chou and colleagues also reported that the downregulation of SLC22A17 significantly reduced the mRNA expression levels of the pro-inflammatory cytokines and MMPs in pancreatic cancer cells [66]. Here, SLC22A17 is linked to pancreatic neoplasm.